Explore more publications!

LeMaitre to Participate at Upcoming Investor Conferences in March

BURLINGTON, Mass., Feb. 27, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in five upcoming investor conferences in March.

Leerink Partners Global Healthcare Conference
Tuesday, March 10, 2026
W South Beach, Miami
Management will present at 1:00 PM EDT

Citizens Life Sciences Conference
Wednesday, March 11, 2026
Eden Roc Miami Beach, Miami
Management will present at 1:40 PM EDT

Barclays Annual Global Healthcare Conference
Thursday, March 12, 2026
Management will be available for 1x1 meetings

KeyBanc Capital Markets Healthcare Forum
Tuesday, March 17, 2026
Virtual
Management will present at 3:45 PM EDT

38th Annual ROTH Conference
March 22-24, 2026
Management will be available for 1x1 meetings and may also participate in a presentation or fireside chat.

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

LeMaitre is a registered trademark of LeMaitre Vascular, Inc.


Contact:
Greg Manker
Director Business Development & Investor Relations
LeMaitre Vascular, Inc.
Phone: (781) 362-1260
Email: gmanker@lemaitre.com

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions